1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione

C24H26ClN5O2S — CID 69026379

IUPAC1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione
SMILESCCCCC1CN(Cc2ccc3c(N)ncnc3c2)C(=O)C(=O)N1C/C=C/c1ccc(Cl)s1
InChIInChI=1S/C24H26ClN5O2S/c1-2-3-5-17-14-29(13-16-7-9-19-20(12-16)27-15-28-22(19)26)23(31)24(32)30(17)11-4-6-18-8-10-21(25)33-18/h4,6-10,12,15,17H,2-3,5,11,13-14H2,1H3,(H2,26,27,28)/b6-4+
InChIKeyQBWGNJQJSYCUHW-GQCTYLIASA-N
MW484.03 g/mol
LogP4.37
Rot. Bonds8

About 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione

1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione (PubChem CID 69026379) has the molecular formula C24H26ClN5O2S and a molecular weight of 484.03 g/mol. Its IUPAC name is 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione.

Molecular Properties

Compound Name1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione
PubChem CID69026379
Molecular FormulaC24H26ClN5O2S
Molecular Weight484.03 g/mol
Exact Mass483.15
IUPAC Name1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione
SMILESCCCCC1CN(Cc2ccc3c(N)ncnc3c2)C(=O)C(=O)N1C/C=C/c1ccc(Cl)s1
InChIInChI=1S/C24H26ClN5O2S/c1-2-3-5-17-14-29(13-16-7-9-19-20(12-16)27-15-28-22(19)26)23(31)24(32)30(17)11-4-6-18-8-10-21(25)33-18/h4,6-10,12,15,17H,2-3,5,11,13-14H2,1H3,(H2,26,27,28)/b6-4+
InChIKeyQBWGNJQJSYCUHW-GQCTYLIASA-N
XLogP4.37
TPSA92.42 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500484.03
LogP ≤ 54.37
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione?
The IUPAC name of 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione (CID 69026379) is 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione.
What is the SMILES notation for 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione?
The canonical SMILES for 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione is CCCCC1CN(Cc2ccc3c(N)ncnc3c2)C(=O)C(=O)N1C/C=C/c1ccc(Cl)s1.
What is the InChIKey of 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione?
The InChIKey is QBWGNJQJSYCUHW-GQCTYLIASA-N. The full InChI is InChI=1S/C24H26ClN5O2S/c1-2-3-5-17-14-29(13-16-7-9-19-20(12-16)27-15-28-22(19)26)23(31)24(32)30(17)11-4-6-18-8-10-21(25)33-18/h4,6-10,12,15,17H,2-3,5,11,13-14H2,1H3,(H2,26,27,28)/b6-4+.
What are the key properties of 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione?
1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione has a molecular weight of 484.03 g/mol, XLogP of 4.37, 8 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(4-aminoquinazolin-7-yl)methyl]-5-butyl-4-[(E)-3-(5-chlorothiophen-2-yl)prop-2-enyl]piperazine-2,3-dione is sourced from PubChem (CID 69026379), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).